Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

CR-000172

News Release

 View printer-friendly version

Charles River Laboratories Management to Address UBS Warburg Global Healthcare Services Conference

WILMINGTON, Mass.--(BUSINESS WIRE)--Jan. 21, 2003--Charles River Laboratories International, Inc. (NYSE:CRL) announced today Senior Vice President and Chief Financial Officer Thomas F. Ackerman will discuss the Company's business outlook at the UBS Warburg Global Healthcare Services Conference in New York on Tuesday, February 4, 2003, at 3:30 p.m. Eastern time.

A live webcast of the presentation will be available through a link that will be posted on the Investor Relations section of the Charles River Laboratories website, http://www.criver.com. A webcast replay will be accessible through the Investor Relations section of the Company's website approximately three hours following the presentation and will remain available until Tuesday, February 11, 2003. The associated slide presentation will be available for downloading during that time.

CONTACT: Charles River Laboratories International, Inc.
Susan E. Hardy, 978/658-6000, ext. 1616


Featured Report

2018 Annual Report (PDF)

Investor Hotline

877-567-6CRL (6275)